Novel Biomarkers of Kidney Diseases: Second Edition
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Biomarkers".
Deadline for manuscript submissions: 15 May 2025 | Viewed by 1585
Special Issue Editors
Interests: immune-mediated kidney disease; diabetic kidney disease; genetic diseases of the kidney; cardiovascular complications of chronic kidney disease
Special Issues, Collections and Topics in MDPI journals
Interests: chronic kidney disease; renal biopsy; IgA nephropathy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Following a very successful first run, we are pleased to announce the launch of the second edition of the Special Issue entitled “Novel Biomarkers of Kidney Diseases”.
With the expanding therapeutic options for treating different chronic kidney diseases, there is an increasing need for the non-invasive diagnosis of glomerular disease and, even more importantly, the assessment of its activity, chronicity (degree of fibrosis), putative outcome, optimal choice and response to treatment. The increase in our understanding of the pathogenesis of chronic kidney disease has resulted in the identification of new potential therapeutic targets. Thus, the aim of this Special Issue is to provide an update on the recent progress in these two areas. We encourage authors to submit papers on the recent advances in biomarkers and the potential therapeutic targets of kidney disease.
Prof. Dr. Vladimír Tesař
Prof. Dr. Dita Maixnerova
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarker
- kidney disease
- fibrosis
- proteomics
- metabolomics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
Related Special Issue
- Novel Biomarkers of Kidney Diseases in Biomolecules (5 articles)
